The US Pharmacopeial Convention (USP) is recalling USP 33?NF 28. The official date for USP 33–NF 28 to go into effect was 1 May 2010. According to a public notice of 12 January 2010, the redesign of ...

The cover story of this issue of Pharmaceutical Technology is devoted to over-the-counter (OTC) medications—how they're regulated, and what safeguards are in place to help ensure their quality and ...

Ganeden Biotech is pleased to announce that GanedenBC 30 (Bacillus coagulans GBI-30, 6086) is the first probiotic to have a monograph published in the Food Chemical Codex (FCC) from the U.S.

Rockville, Md., March 17, 2008 — The U.S. Pharmacopeial (USP) Convention today announced a revised Glycerin monograph in the United States Pharmacopeia (USP), an official compendium of the United ...

Rockville, Md., November 15, 2007 — The U.S. Pharmacopeia (USP) is pleased to announce 11 new proposed monographs for dietary supplements for public notice and comment. Six Turmeric-related monographs ...

RAPS.org needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site such as ...

A new study released in the journal PLOS One found that on average, drugs with a public quality standard developed by the U.S. Pharmacopeia had approximately 50% more generic manufacturers compared ...

Atorvastatin, a widely prescribed statin drug, is used to lower cholesterol levels and reduce the risk of cardiovascular diseases.1,2 To ensure the safety and efficacy of this drug, it is essential to ...

Utilizing the United States Pharmacopeia and National Formulary (USP-NF) monographs enables pharmaceutical labs and manufacturers to meet strict quality regulations regarding drugs and formulations.

On March 12, 2020, an Appeals Panel of the United States Pharmacopeial Convention (“USP”) granted appeals to revisions of two compounding standards—General Chapter <795> Pharmaceutical Compounding – ...